Melanie E. Davis

2.5k total citations
24 papers, 1.1k citations indexed

About

Melanie E. Davis is a scholar working on Molecular Biology, Genetics and Plant Science. According to data from OpenAlex, Melanie E. Davis has authored 24 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 11 papers in Genetics and 4 papers in Plant Science. Recurrent topics in Melanie E. Davis's work include Chronic Lymphocytic Leukemia Research (11 papers), Histone Deacetylase Inhibitors Research (5 papers) and Ubiquitin and proteasome pathways (4 papers). Melanie E. Davis is often cited by papers focused on Chronic Lymphocytic Leukemia Research (11 papers), Histone Deacetylase Inhibitors Research (5 papers) and Ubiquitin and proteasome pathways (4 papers). Melanie E. Davis collaborates with scholars based in United States, Italy and Canada. Melanie E. Davis's co-authors include David Lucas, Michael R. Grever, John C. Byrd, Mark R. Parthun, A. Raymond Miller, John C. Byrd, Shinichi Kitada, John C. Reed, Joseph Wickham and Andrew P. Mone and has published in prestigious journals such as The Journal of Cell Biology, Blood and PLoS ONE.

In The Last Decade

Melanie E. Davis

24 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Melanie E. Davis United States 17 854 330 202 169 168 24 1.1k
Alexei Vassilev United States 21 574 0.7× 231 0.7× 287 1.4× 119 0.7× 319 1.9× 49 1.4k
Annalisa Lonetti Italy 24 824 1.0× 280 0.8× 251 1.2× 73 0.4× 157 0.9× 57 1.5k
Joseph R. Garlich United States 17 735 0.9× 115 0.3× 210 1.0× 140 0.8× 100 0.6× 33 1.1k
Vanda Pogačić Switzerland 9 1.1k 1.3× 71 0.2× 227 1.1× 299 1.8× 73 0.4× 12 1.5k
Mercè de Frías Spain 13 511 0.6× 184 0.6× 237 1.2× 94 0.6× 103 0.6× 17 734
Malgorzata Nieborowska-Skorska United States 15 765 0.9× 430 1.3× 404 2.0× 238 1.4× 160 1.0× 17 1.5k
Jaira F. de Vasconcellos United States 14 549 0.6× 195 0.6× 136 0.7× 42 0.2× 162 1.0× 33 910
Vicente Fresquet Spain 16 442 0.5× 154 0.5× 166 0.8× 132 0.8× 105 0.6× 24 703
Mayuko Omori United States 10 883 1.0× 77 0.2× 294 1.5× 74 0.4× 76 0.5× 14 1.2k
Bibiana I. Ferreira Portugal 17 633 0.7× 59 0.2× 108 0.5× 89 0.5× 199 1.2× 34 965

Countries citing papers authored by Melanie E. Davis

Since Specialization
Citations

This map shows the geographic impact of Melanie E. Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melanie E. Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melanie E. Davis more than expected).

Fields of papers citing papers by Melanie E. Davis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melanie E. Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melanie E. Davis. The network helps show where Melanie E. Davis may publish in the future.

Co-authorship network of co-authors of Melanie E. Davis

This figure shows the co-authorship network connecting the top 25 collaborators of Melanie E. Davis. A scholar is included among the top collaborators of Melanie E. Davis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melanie E. Davis. Melanie E. Davis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Contreras, J., et al.. (2020). Early posttherapy clearance of human papillomavirus and treatment response in cervical carcinoma. Cancer. 126(18). 4168–4176. 2 indexed citations
2.
Bertino, Erin M., Elizabeth L. McMichael, Xiaokui Mo, et al.. (2016). A Phase I Trial to Evaluate Antibody-Dependent Cellular Cytotoxicity of Cetuximab and Lenalidomide in Advanced Colorectal and Head and Neck Cancer. Molecular Cancer Therapeutics. 15(9). 2244–2250. 22 indexed citations
3.
McMichael, Elizabeth L., Megan Duggan, Melanie E. Davis, et al.. (2016). Abstract CT143: A phase I/II trial of cetuximab in combination with interleukin-12 administered to patients with unresectable primary or recurrent squamous cell carcinoma of the head and neck. Cancer Research. 76(14_Supplement). CT143–CT143. 1 indexed citations
4.
Gupta, Sneha, Erin Hertlein, Yanhui Lu, et al.. (2013). The Proteasome Inhibitor Carfilzomib Functions Independently of p53 to Induce Cytotoxicity and an Atypical NF-κB Response in Chronic Lymphocytic Leukemia Cells. Clinical Cancer Research. 19(9). 2406–2419. 31 indexed citations
5.
Woyach, Jennifer A., Engin Bojnik, Amy S. Ruppert, et al.. (2013). Bruton’s tyrosine kinase (BTK) function is important to the development and expansion of chronic lymphocytic leukemia (CLL). Blood. 123(8). 1207–1213. 156 indexed citations
6.
Woyach, Jennifer A., Matthew Stefanovski, Virginia M. Goettl, et al.. (2012). Global Inhibition of Bruton's Tyrosine Kinase (BTK) Delays the Development and Expansion of Chronic Lymphocytic Leukemia (CLL) in the TCL1 Mouse Model of Disease. Blood. 120(21). 183–183. 3 indexed citations
7.
Gupta, Sneha, Ellen J. Sass, Melanie E. Davis, et al.. (2011). Resistance to the Translation Initiation Inhibitor Silvestrol is Mediated by ABCB1/P-Glycoprotein Overexpression in Acute Lymphoblastic Leukemia Cells. The AAPS Journal. 13(3). 357–64. 63 indexed citations
8.
Lucas, David, Lapo Alinari, Melanie E. Davis, et al.. (2010). The Novel Deacetylase Inhibitor AR-42 Demonstrates Pre-Clinical Activity in B-Cell Malignancies In Vitro and In Vivo. PLoS ONE. 5(6). e10941–e10941. 43 indexed citations
9.
Su, Xiaodan, David Lucas, Liwen Zhang, et al.. (2009). Validation of an LC‐MS based approach for profiling histones in chronic lymphocytic leukemia. PROTEOMICS. 9(5). 1197–1206. 17 indexed citations
10.
Blum, Kristie A., Richard van der Jagt, Joseph Brandwein, et al.. (2009). Phase II study of the histone deacetylase inhibitor MGCD0103 in patients with previously treated chronic lymphocytic leukaemia. British Journal of Haematology. 147(4). 507–514. 94 indexed citations
11.
Lucas, David, Ryan B. Edwards, Gerard Lozanski, et al.. (2009). The novel plant-derived agent silvestrol has B-cell selective activity in chronic lymphocytic leukemia and acute lymphoblastic leukemia in vitro and in vivo. Blood. 113(19). 4656–4666. 138 indexed citations
12.
Awan, Farrukh T., Neil E. Kay, Melanie E. Davis, et al.. (2008). Mcl-1 expression predicts progression-free survival in chronic lymphocytic leukemia patients treated with pentostatin, cyclophosphamide, and rituximab. Blood. 113(3). 535–537. 60 indexed citations
13.
Su, Xiaodan, Naduparambil K. Jacob, Ravindra Amunugama, et al.. (2007). Liquid chromatography mass spectrometry profiling of histones. Journal of Chromatography B. 850(1-2). 440–454. 28 indexed citations
14.
Su, Xiaodan, Liwen Zhang, David Lucas, et al.. (2006). Histone H4 acetylation dynamics determined by stable isotope labeling with amino acids in cell culture and mass spectrometry. Analytical Biochemistry. 363(1). 22–34. 16 indexed citations
15.
Lucas, David, Melanie E. Davis, Mark R. Parthun, et al.. (2004). The histone deacetylase inhibitor MS-275 induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia cells. Leukemia. 18(7). 1207–1214. 115 indexed citations
16.
17.
Davis, Melanie E., A. Raymond Miller, & R. Daniel Lineberger. (1992). Studies on the Effects of Ethylene on Transformation of Tomato Cotyledons (Lycopersicon esculentum Mill.) by Agrobacterium tumefaciens. Journal of Plant Physiology. 139(3). 309–312. 20 indexed citations
18.
19.
Balducci, Lodovico, Brent A. Blumenstein, Daniel D. Von Hoff, et al.. (1987). Evaluation of fludarabine phosphate in renal cell carcinoma: a Southwest Oncology Group Study.. PubMed. 71(5). 543–4. 10 indexed citations
20.
Stewart, Kenneth D., Gary L. Floyd, Karl R. Mattox, & Melanie E. Davis. (1972). CYTOCHEMICAL DEMONSTRATION OF A SINGLE PEROXISOME IN A FILAMENTOUS GREEN ALGA. The Journal of Cell Biology. 54(2). 431–434. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alexei Vassilev Breakdown of academic impact, for papers by Annalisa Lonetti Breakdown of academic impact, for papers by Joseph R. Garlich Breakdown of academic impact, for papers by Vanda Pogačić Breakdown of academic impact, for papers by Mercè de Frías Breakdown of academic impact, for papers by Malgorzata Nieborowska-Skorska Breakdown of academic impact, for papers by Jaira F. de Vasconcellos Breakdown of academic impact, for papers by Vicente Fresquet Breakdown of academic impact, for papers by Mayuko Omori Breakdown of academic impact, for papers by Bibiana I. Ferreira
Rankless by CCL
2026